BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22517617)

  • 1. Re: Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
    Deltour N; Coste M; Tupinon-Mathieu I
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):584-5; author reply 586-8. PubMed ID: 22517617
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
    Fournier A; Zureik M
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benfluorex-induced cardiac valve injury.
    Acar J
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1243-4; author reply 1245-6. PubMed ID: 23109237
    [No Abstract]   [Full Text] [Related]  

  • 4. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
    Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benfluorex: how many deaths?
    Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
    [No Abstract]   [Full Text] [Related]  

  • 6. Benfluorex: left heart valve disease very common.
    Prescrire Int; 2014 May; 23(149):128. PubMed ID: 24926516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Valvular heart disease associated with benfluorex].
    Rafel Ribera J; Casañas Muñoz R; Anguera Ferrando N; Batalla Sahún N; Castro Cels A; Pujadas Capmany R
    Rev Esp Cardiol; 2003 Feb; 56(2):215-6. PubMed ID: 12605770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benfluorex: the last chapter of drug-induced valvular heart disease?
    Droogmans S; Cosyns B; Van Camp G
    Eur J Echocardiogr; 2011 Apr; 12(4):263-4. PubMed ID: 21193483
    [No Abstract]   [Full Text] [Related]  

  • 9. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcifications in benfluorex-induced valve heart disease: a misknown association.
    Plurien F; Bruneval P; Jobic Y; Iung B; Ennezat PV
    Cardiology; 2015; 130(2):87-90. PubMed ID: 25614032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitral and aortic valvular disease associated with benfluorex use.
    Etienne Y; Jobic Y; Frachon I; Fatemi M; Castellant P; Quintin-Roué I
    J Heart Valve Dis; 2011 May; 20(3):348-50. PubMed ID: 21714428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
    Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
    [No Abstract]   [Full Text] [Related]  

  • 13. Valvular heart disease associated with benfluorex.
    Gueffet JP; Piriou N; Trochu JN
    Arch Cardiovasc Dis; 2010 May; 103(5):342-3. PubMed ID: 20619246
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
    Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
    Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine-like cardiovascular side-effects of benfluorex.
    Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
    Baufreton C; Bruneval P; Rousselet MC; Ennezat PV; Fouquet O; Giraud R; Banfi C
    Medicine (Baltimore); 2017 Jan; 96(2):e4985. PubMed ID: 28079786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.
    Le Ven F; Tribouilloy C; Habib G; Gueffet JP; Maréchaux S; Eicher JC; Blanchard-Lemoine B; Rousseau J; Hénon P; Jobic Y; Etienne Y
    Eur J Echocardiogr; 2011 Apr; 12(4):265-71. PubMed ID: 21193484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.
    Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G
    Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benfluorex and cardiac valve disease: long delay in publication.
    Prescrire Int; 2013 Feb; 22(135):47. PubMed ID: 23444509
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex?
    Le Ven F; Alavi Z; Jobic Y; Etienne Y; Didier R; Porcher R
    PLoS One; 2016; 11(8):e0160011. PubMed ID: 27487042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.